Canada - English - Health Canada

purdue pharma - tramadol hydrochloride - tablet (extended-release) - 400mg - tramadol hydrochloride 400mg - opiate agonists

Canada - English - Health Canada

purdue pharma - tramadol hydrochloride - tablet (extended-release) - 75mg - tramadol hydrochloride 75mg - opiate agonists

Canada - English - Health Canada

purdue pharma - tramadol hydrochloride - tablet (extended-release) - 100mg - tramadol hydrochloride 100mg - opiate agonists

Singapore - English - HSA (Health Sciences Authority)

novartis (singapore) pte ltd - ketotifen fumarate 0.345mg eqv ketotifen - solution - 0.25 mg/ml - ketotifen fumarate 0.345mg eqv ketotifen 0.25 mg/ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

gw pharma ltd - cannabidiol; dronabinol - spray - 2.5mg/1dose ; 2.7mg/1dose

Singapore - English - HSA (Health Sciences Authority)

roche singapore pte. ltd. - tocilizumab - infusion, solution concentrate - 20mg/ml - tocilizumab 20mg/ml

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

abbvie sdn bhd - upadacitinib hemihydrate -

Israel - English - Ministry of Health

abbvie biopharmaceuticals ltd, israel - upadacitinib as hemihydrate - tablets prolonged release - upadacitinib as hemihydrate 45 mg - upadacitinib - ulcerative colitisrinvoq is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biologic agent.crohn’s diseaserinvoq is indicated for the treatment of adult patients with moderately to severely active crohn’s disease who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biologic agent.

Israel - English - Ministry of Health

glaxo smith kline (israel) ltd - mepolizumab - solution for injection - mepolizumab 100 mg / 1 ml - mepolizumab - severe eosinophilic asthmanucala is indicated as an add-on treatment for severe refractory eosinophilic asthma in adult patientschronic rhinosinusitis with nasal polyps (crswnp)nucala is indicated as an add-on therapy with intranasal corticosteroids for the treatment of adult patients with severe crswnp for whom therapy with corticosteroids and surgery in the last 10 years do not provide adequate disease control.eosinophilic granulomatosis with polyangiitis (egpa)nucala is indicated for the treatment of adult patients with eosinophilic granulomatosis with polyangiitis (egpa).hypereosinophilic syndrome (hes)nucala is indicated as an add-on treatment for adult patients with inadequately controlled hypereosinophilic syndrome without an identifiable non-haematologic secondary cause.

Ireland - English - HPRA (Health Products Regulatory Authority)

as kalceks - meropenem trihydrate - powder for solution for injection/infusion - meropenem